Skip to main content

Table 4 Univariate log-rank test of prognostic covariates in 130 patients with oral cavity squamous cell carcinoma regarding disease-free and overall survival

From: Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma

 

DFS, P value

OS, P value

 

[HR (95 % CI)]

[HR (95 % CI)]

Age (years)

 <50

0.251

0.885

 ≥50

0.678 (0.349–1.316)

0.938 (0.395–2.228)

Sex

 Female

0.776

0.164

 Male

1.163 (0.411–3.297)

0.490 (0.179–1.337)

Nodal status

 (−) metastasis, (−) ECS

0.001

0.008

 (+) metastasis, (−) ECS

1.193 (0.384–3.705)

1.858 (0.463–7.447)

 (+) metastasis, (+) ECS

3.586 (1.733–7.420)

4.618 (1.729–12.338)

Differentiation

 Well/moderate

0.027

0.041

 Poor

2.437 (1.105–5.372)

2.868 (1.043–7.886)

Pathologic tumor status

 Earlya

0.023

0.096

 Advancedb

2.172 (1.111–4.247)

2.084 (0.877–4.949)

CRP

 <5 mg/mL

0.016

0.027

 ≥5 mg/mL

2.274 (1.163–4.448)

2.636 (1.118–6.217)

Cyfra 21-1

 <3.3 ng/mL

0.135

0.667

 ≥3.3 ng/mL

1.885 (0.821–4.328)

0.726 (0.169–3.120)

Tumor depth

 <10 mm

0.030

0.052

 ≥10 mm

2.207 (1.080–4.510)

2.560 (0.991–6.613)

Cyfra 21-1 and CRP

0.019

0.235

 Cyfra 21-1 < 3.3 ng/mL, CRP < 5 mg/L

1

1

 Cyfra 21-1 ≥ 3.3 ng/mL, CRP < 5 mg/L

0.575 (0.077–4.300)

0.000 (0.000)

 Cyfra 21-1 < 3.3 ng/mL, CRP ≥ 5 mg/L

1.683 (0.761–3.722)

2.578 (1.036–6.414)

 Cyfra 21-1 ≥ 3.3 ng/mL, CRP ≥ 5 mg/L

4.065 (1.610–10.261)

1.928 (0.426–8.726)

  1. ECS extra-capsular spread
  2. aT1–T2
  3. bT3–T4